Literature DB >> 23943472

Presence of diadenosine polyphosphates in microdialysis samples from rat cerebellum in vivo: effect of mild hyperammonemia on their receptors.

Javier Gualix1, Rosa Gómez-Villafuertes, Jesús Pintor, Marta Llansola, Vicente Felipo, M Teresa Miras-Portugal.   

Abstract

Diadenosine triphosphate (Ap(3)A), diadenosine tetraphosphate (Ap(4)A), and diadenosine pentaphosphate (Ap(5)A) have been identified in microdialysis samples from the cerebellum of conscious freely moving rats, under basal conditions, by means of a high-performance liquid chromatography method. The occurrence of Ap(3)A in the cerebellar microdyalisates is noteworthy, as the presence of this compound in the interstitial medium in neural tissues has not been previously described. The concentrations measured for the diadenosine polyphosphates in the cerebellar dialysate were (in nanomolar) 10.5 ± 2.9, 5.4 ± 1.2, and 5.8 ± 1.3 for Ap(3)A, Ap(4)A, and Ap(5)A, respectively. These concentrations are in the range that allows the activation of the presynaptic dinucleotide receptor in nerve terminals. However, a possible interaction of these dinucleotides with other purinergic receptors cannot be ruled out, as rat cerebellum expresses a variety of P2X or P2Y receptors susceptible to be activated by diadenosine polyphosphates, such as the P2X1-4, P2Y(1), P2Y(2), P2Y(4), and P2Y(12) receptors, as demonstrated by quantitative real-time PCR. Also, the ecto-nucleotide pyrophosphatases/phosphodiesterases NPP1 and NPP3, able to hydrolyze the diadenosine polyphosphates and terminate their extracellular actions, are expressed in the rat cerebellum. All these evidences contribute to reinforce the role of diadenosine polyphosphates as signaling molecules in the central nervous system. Finally, we have analyzed the possible differences in the concentration of diadenosine polyphosphates in the cerebellar extracellular medium and changes in the expression levels of their receptors and hydrolyzing enzymes in an animal model of moderate hyperammonemia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23943472      PMCID: PMC4040178          DOI: 10.1007/s11302-013-9382-3

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  39 in total

1.  Distribution of [3H]diadenosine tetraphosphate binding sites in rat brain.

Authors:  F Rodríguez-Pascual; R Cortes; M Torres; J M Palacios; M T Miras-Portugal
Journal:  Neuroscience       Date:  1997-03       Impact factor: 3.590

2.  Selectivity and activity of adenine dinucleotides at recombinant P2X2 and P2Y1 purinoceptors.

Authors:  J Pintor; B F King; M T Miras-Portugal; G Burnstock
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

3.  Synthesis of (di)nucleoside polyphosphates by the ubiquitin activating enzyme E1.

Authors:  Maria A Günther Sillero; Anabel de Diego; Eduardo Silles; Antonio Sillero
Journal:  FEBS Lett       Date:  2005-10-14       Impact factor: 4.124

4.  Selectivity of diadenosine polyphosphates for rat P2X receptor subunits.

Authors:  S S Wildman; S G Brown; B F King; G Burnstock
Journal:  Eur J Pharmacol       Date:  1999-02-12       Impact factor: 4.432

Review 5.  The effects of diadenosine polyphosphates on the cardiovascular system.

Authors:  N A Flores; B M Stavrou; D J Sheridan
Journal:  Cardiovasc Res       Date:  1999-04       Impact factor: 10.787

6.  Dinucleotide receptor modulation by protein kinases (protein kinases A and C) and protein phosphatases in rat brain synaptic terminals.

Authors:  J Pintor; J Gualix; M T Miras-Portugal
Journal:  J Neurochem       Date:  1997-06       Impact factor: 5.372

7.  Characterization of nucleotide transport into rat brain synaptic vesicles.

Authors:  J Gualix; J Pintor; M T Miras-Portugal
Journal:  J Neurochem       Date:  1999-09       Impact factor: 5.372

8.  Diadenosine polyphosphates evoke Ca2+ transients in guinea-pig brain via receptors distinct from those for ATP.

Authors:  J Pintor; J A Puche; J Gualix; C H Hoyle; M T Miras-Portugal
Journal:  J Physiol       Date:  1997-10-15       Impact factor: 5.182

9.  Chronic hyperammonemia impairs the glutamate-nitric oxide-cyclic GMP pathway in cerebellar neurons in culture and in the rat in vivo.

Authors:  C Hermenegildo; C Montoliu; M Llansola; M D Muñoz; J M Gaztelu; M D Miñana; V Felipo
Journal:  Eur J Neurosci       Date:  1998-10       Impact factor: 3.386

10.  Second messenger cascade specificity and pharmacological selectivity of the human P2Y1-purinoceptor.

Authors:  J B Schachter; Q Li; J L Boyer; R A Nicholas; T K Harden
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

View more
  1 in total

Review 1.  The purinergic neurotransmitter revisited: a single substance or multiple players?

Authors:  Violeta N Mutafova-Yambolieva; Leonie Durnin
Journal:  Pharmacol Ther       Date:  2014-06-02       Impact factor: 12.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.